These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18950377

  • 1. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.
    Muraki I, Inoue T, Hashimoto S, Izumi T, Koyama T.
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):568-74. PubMed ID: 18950377
    [Abstract] [Full Text] [Related]

  • 2. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE, Gonzalez-Lira V, Horrillo I, Herrera-Marschitz M, Callado LF, Meana JJ.
    Eur J Pharmacol; 2013 Jun 05; 709(1-3):13-9. PubMed ID: 23562616
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Höök BB, Hacksell U, Svensson TH.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May 05; 353(6):630-40. PubMed ID: 8738296
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
    Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW.
    Br J Pharmacol; 2004 Jun 05; 142(3):469-78. PubMed ID: 15148253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action].
    Hashimoto S.
    Hokkaido Igaku Zasshi; 2000 Nov 05; 75(6):421-36. PubMed ID: 11193934
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2007 Nov 05; 21(8):795-804. PubMed ID: 17984160
    [Abstract] [Full Text] [Related]

  • 12. Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex.
    Gołembiowska K, Dziubina A.
    Pol J Pharmacol; 2000 Nov 05; 52(6):441-8. PubMed ID: 11334237
    [Abstract] [Full Text] [Related]

  • 13. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
    Tao R, Ma Z, Auerbach SB.
    J Pharmacol Exp Ther; 2000 Aug 05; 294(2):571-9. PubMed ID: 10900234
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.
    J Neurochem; 2003 Jul 05; 86(1):13-24. PubMed ID: 12807420
    [Abstract] [Full Text] [Related]

  • 15. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R, Velasco C, Bramante M, Longo A, Samanin R.
    Neuropharmacology; 1997 Jul 05; 36(4-5):467-73. PubMed ID: 9225271
    [Abstract] [Full Text] [Related]

  • 16. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S, Westlin D, Bengtsson HJ.
    Neuropharmacology; 1997 Jul 05; 36(4-5):461-5. PubMed ID: 9225270
    [Abstract] [Full Text] [Related]

  • 17. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
    Ferraro L, Fuxe K, Agnati L, Tanganelli S, Tomasini MC, Antonelli T.
    Synapse; 2005 Mar 15; 55(4):230-41. PubMed ID: 15668907
    [Abstract] [Full Text] [Related]

  • 18. Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activity.
    Mällo T, Kõiv K, Koppel I, Raudkivi K, Uustare A, Rinken A, Timmusk T, Harro J.
    Brain Res; 2008 Feb 15; 1194(5):110-7. PubMed ID: 18177844
    [Abstract] [Full Text] [Related]

  • 19. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
    Kleijn J, Cremers TI, Hofland CM, Westerink BH.
    Neurosci Res; 2011 Jul 15; 70(3):334-7. PubMed ID: 21420449
    [Abstract] [Full Text] [Related]

  • 20. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
    Gundlah C, Hjorth S, Auerbach SB.
    Neuropharmacology; 1997 Jul 15; 36(4-5):475-82. PubMed ID: 9225272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.